Tag: South African Business

  • Fake Medical Certificates Fuel Sick Leave Abuse

    Recent allegations that high-profile figures feigned illness to avoid appearing before the Madlanga Commission of Inquiry have placed fake medical certificates under renewed scrutiny. Labour experts warn that fraudulent sick notes are widely used by employees seeking time away from work without valid medical reasons. The practice adds to workplace absenteeism, reduces productivity and increases costs for employers. Online healthcare…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Aspen Shares Nosedive 15% on JSE After Shock Profit Warning

    Shares in pharmaceutical giant Aspen Pharmacare took a sharp dive in early trading on Friday. They slumped by as much as 15% after the company issued a profit warning for its financial year ending in June. The announcement cited significant impairments totalling R4.1 billion and increased restructuring costs as primary drivers for the expected drop in earnings. Consequently, the announcement…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Adcock Ingram to Delist Amidst Corporate Changes

    Adcock Ingram, the pharmaceutical giant behind household brands such as Panado and Corenza-C, could delist from the Johannesburg Stock Exchange (JSE). This follows a significant deal between its majority shareholder, Bidvest, and Indian drugmaker Natco Pharma. The news saw Adcock’s share price surge by 24%. Under the terms of the agreement, Indian-listed Natco Pharma will acquire a significant minority stake…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • The Ascendis Health Turnaround: From Debt to Profitability

    Ascendis Health was once a darling of the JSE. It was listed in 2013. Its aggressive global plan nearly led to collapse, but now The Ascendis Health Turnaround is aiming to rectify past mistakes. Excessive debt fueled the company’s strategy. The plan to create a health giant faltered. Acquisitions lacked synergy, and offshore assets underperformed. The massive debt burden proved…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in